Fagron NV is a publicly traded multinational company governed by Belgian law, specializing in pharmaceutical compounding to enable personalized medicine for hospitals, pharmacies, clinics, and patients worldwide. Headquartered in Rotterdam, Netherlands, with its registered office in Waregem, Belgium, it supplies essential raw materials, semi-finished products, vehicles, packaging, laboratory equipment, and compounding software under its own brand. The company offers sterile and non-sterile compounding services, outsourcing solutions, and pharmacogenomic testing like TrichoTest to support tailored therapies. Active in over 35 countries across Europe, North America, Latin America, Asia-Pacific, Africa, and beyond, Fagron NV serves more than 150,000 customers through operational excellence and strategic acquisitions, such as Amber Compounding Pharmacy in Singapore and Malaysia, and Vepakum in Brazil. Founded in 1990 by Ger van Jeveren, it evolved from raw materials distribution to a global leader, employing nearly 4,000 people and driving innovation in personalized treatments to address drug shortages, enhance patient outcomes, and meet individual healthcare needs.